Barua Sumita, Phua Bernadette, Orr Yishay, Skinner Michael
Department of Cardiology, Westmead Hospital, Hawkesbury Road, Westmead NSW 2145, Australia.
Department of Cardiothoracics, Westmead Hospital, Hawkesbury Road, Westmead NSW 2145, Australia.
Eur Heart J Case Rep. 2020 Sep 27;4(5):1-6. doi: 10.1093/ehjcr/ytaa208. eCollection 2020 Oct.
We present a 23-year-old Nepalese migrant with mycobacterial tuberculosis (TB) pericarditis manifesting as effusive constrictive disease and subsequent rapid progression to constrictive pericarditis resulting from bulky granulomatous disease.
Following initial presumptive diagnosis of TB pericarditis based on presence of moderate pericardial effusion and positive polymerase chain reaction on concurrent pleural aspirate, the patient was managed with standard empiric therapy. Despite treatment, he developed progressive heart failure with New York Heart Association (NYHA) class III symptoms and had confirmation of constrictive physiology on simultaneous left and right heart catheterization. He underwent pericardiectomy 4 months after his initial diagnosis, with debridement of large necrotizing granulomas and an associated immediate improvement clinical improvement. He remains well at 6-month follow-up with no residual heart failure symptoms off diuretic therapy.
Tuberculous pericarditis accounts for 1-2% of presentations with TB infection, with progression to constrictive pericarditis in between 17 and 40% of cases. To date, pericardiectomy remains mainstay of treatment for constriction, albeit with high perioperative risk. In combination with anti-tuberculous therapy, prednisone and pericardiocentesis may reduce risk of progression to constriction, however, neither have shown mortality benefit. Our patient continued to progress, despite medical therapy and proceeded to pericardiectomy only 4 months after his initial diagnosis, with rapid improvement in symptoms, demonstrating the importance of close monitoring and revision of management strategy in these patients.
我们报告一名23岁的尼泊尔移民,患有分枝杆菌性结核性心包炎,表现为渗出性缩窄性疾病,随后因大量肉芽肿性疾病迅速进展为缩窄性心包炎。
根据中度心包积液的存在以及同期胸腔穿刺液聚合酶链反应阳性,初步推定诊断为结核性心包炎后,该患者接受了标准经验性治疗。尽管进行了治疗,但他仍出现进行性心力衰竭,纽约心脏协会(NYHA)心功能分级为III级,同时左右心导管检查证实存在缩窄性生理改变。在初次诊断4个月后,他接受了心包切除术,清除了大量坏死性肉芽肿,临床症状随即得到改善。在6个月的随访中,他情况良好,停用利尿剂治疗后无残余心力衰竭症状。
结核性心包炎占结核病感染病例的1%-2%,其中17%-40%的病例会进展为缩窄性心包炎。迄今为止,心包切除术仍然是治疗缩窄的主要方法,尽管围手术期风险很高。联合抗结核治疗、泼尼松和心包穿刺术可能会降低进展为缩窄的风险,然而,两者均未显示出对死亡率的益处。我们的患者尽管接受了药物治疗仍继续进展,在初次诊断仅4个月后就接受了心包切除术,症状迅速改善,这表明对这些患者进行密切监测和调整管理策略的重要性。